• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 5/7/24: Challenges With Feasibility Studies, AI Has ‘Enormous Potential for Harm’ & more


The latest news for pharma industry insiders.

Challenges With Feasibility Studies

In part 3 of this video interview with ACT editor Andy Studna, Rohit Nambisan, CEO & founder of Lokavant analyzes some of the most common mistakes he has seen stakeholders make in feasibility studies and how they can be addressed.

Supporting Fertility: The Pharmacist's Vital Role During and After National Infertility Awareness Week

Pharmacists play a multifaceted role beyond dispensing medications, serving as educators, counselors, advocates, and pillars of emotional support for individuals and couples confronting infertility.

Warren Buffett Fears AI Has ‘Enormous Potential for Harm’

The Berkshire Hathaway CEO compares artificial intelligence to the development of nuclear weaponry, even as the company begins to use it in some businesses.

OM1 Launches Three New Products Powered by Patented AI Platform to Expedite Delivery of Personalized Medicine

The company is introducing OM1 Orion, OM1 Lyra, and OM1 Polaris, aligning AI technology and real-world data to offer unprecedented insights into the patient journey and further patient outcomes through prediction, precision, and discovery.

Renu Nadkarni on LinkedIn:

I'm excited to share this new piece featured by Pharmaceutical Executive on the new ways technology is revolutionizing observational research!

In this Q&A, industry leader Nancy A. Dreyer talks about the value of PicnicHealth's approach of combining direct-to-patient methods with cutting-edge technology to run more efficient and comprehensive research with greater transparency.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs